Supporting data for “Immunoprofiling as biomarkers for responses to immunotherapy in advanced hepatocellular carcinoma”

Presented data contains immune profile of four independent cohorts as advanced HCC patients who has responded to immunotherapy, advanced HCC patients who has progressed disease after immunotherapy, newly diagnosed HCC patients at advanced stage (HKLC staging system), and healthy subjects from Hong Kong Red Cross. Immune profile contains major types of immune cells such as conventional and unconventional T cell, NK cell, B cell, MDSCs.